Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 17, Issue 8, Pages 1148-1156
Publisher
Oxford University Press (OUP)
Online
2015-02-03
DOI
10.1093/neuonc/nou364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma survival
- (2014) Adelheid Woehrer et al. CURRENT OPINION IN NEUROLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
- (2014) K. M. Schmainda et al. NEURO-ONCOLOGY
- Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Predictive Biomarkers for Bevacizumab: Are We There Yet?
- (2013) D. Maru et al. CLINICAL CANCER RESEARCH
- Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study
- (2013) J. L. Boxerman et al. NEURO-ONCOLOGY
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Bevacizumab for Glioblastoma—A Promising Drug or Not?
- (2013) Motoo Nagane et al. Cancers
- The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard
- (2012) J. L. Boxerman et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
- (2012) Petra Hamerlik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
- (2010) Tao Xu et al. BMC CANCER
- Bevacizumab
- (2010) Marit D. Moen DRUGS
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons
- (2010) Devyani Bedekar et al. MAGNETIC RESONANCE IN MEDICINE
- Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
- (2009) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- (2009) Joost JC Verhoeff et al. BMC CANCER
- Relative cerebral blood volume measurements of low-grade gliomas predict patient outcome in a multi-institution setting
- (2009) Gisele B. Caseiras et al. EUROPEAN JOURNAL OF RADIOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma
- (2009) Susan M. Chang et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- The parametric response map is an imaging biomarker for early cancer treatment outcome
- (2009) Craig J Galbán et al. NATURE MEDICINE
- Brain Tumor Imaging in Clinical Trials
- (2008) J.W. Henson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
- (2008) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study
- (2008) T. Hirai et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
- (2008) Forrest W. Crawford et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
- (2008) R. M. Zuniga et al. JOURNAL OF NEURO-ONCOLOGY
- Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
- (2008) Suja Saraswathy et al. JOURNAL OF NEURO-ONCOLOGY
- Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
- (2008) Ashwatha Narayana et al. JOURNAL OF NEUROSURGERY
- Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
- (2008) Alba A. Brandes et al. NEURO-ONCOLOGY
- Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
- (2008) Eric S. Paulson et al. RADIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started